EFFICACY AND SAFETY OF LAROTRECTINIB IN PAEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER: AN EXTENDED FOLLOW-UP

被引：0

作者：

Zwaan, C. Michel ^{[1
]}

Van Tilburg, Cornelis ^{[2
,3
]}

Doz, Francois ^{[4
,5
]}

Albert, Catherine ^{[6
]}

Blattmann, Claudia ^{[7
]}

Geoerger, Birgit ^{[8
]}

Dubois, Steven ^{[9
]}

Federman, Noah ^{[10
]}

Mascarenhas, Leo ^{[11
]}

Nagasubramanian, Rama ^{[12
]}

Pappo, Alberto ^{[13
]}

Watt, Tanya ^{[14
]}

Norenberg, Ricarda ^{[15
]}

Dima, Laura ^{[16
]}

De la Cuesta, Esther ^{[17
]}

Laetsch, Theodore ^{[18
]}

Xu, Ruihua ^{[19
]}

机构：

[1] Princess Maxima Ctr Pediat Oncol, Stem Cell Transplantat Unit, Utrecht, Netherlands

[2] ErasmusMC Sophias Childrens Hosp, Pediat Oncol, Rotterdam, Netherlands

[3] Heidelberg Univ Hosp, German Canc Res Ctr DKFZ, Hopp Childrens Canc Ctr Heidelberg kitz, Heidelberg, Germany

[4] SIREDO Oncol Ctr Care, Inst Curie, Innovat & Res Children & AYA Canc, Paris, France

[5] Univ Paris Cite, Pediat, Paris, France

[6] Univ Washington Sch Med, Seattle Childrens Hosp, Dept Hematol Oncol, Seattle, WA USA

[7] Olgahospital, Dept Haematol & Oncol, Stuttgart, Germany

[8] Univ Paris Saclay, Gustave Roussy Canc Ctr, Dept Pediat & Adolescent Oncol, Villejuif, France

[9] Dana Farber Hosp, Childrens Canc & Blood Disorders Ctr, Boston, MA USA

[10] David Geffen Sch Med, UCLA Jonsson Comprehensive Canc Ctr, Pediat Hematol Oncol, Los Angeles, CA USA

[11] Univ Southern Calif Keck Sch Med, Childrens Hosp Angeles, Canc & Blood Dis Inst, Dept Hematol Oncol, Los Angeles, CA USA

[12] Childrens Hosp, Dept Hematol Oncol, Orlando, FL USA

[13] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA

[14] Univ Texas, SouthWestern Med Ctr, Dept Pediat, Austin, TX USA

[15] Chrestos Concept GmbH Co KG, Essen, Germany

[16] Bayer HealthCare SAS, Med Affairs, Garenne Colombes, France

[17] Bayer HealthCare Pharmaceut Inc, Oncol, Whippany, NJ USA

[18] Univ Pennsylvania, Childrens Hosp Philadelphia, Dev Therapeut Program, Philadelphia, PA USA

[19] Sun Yat sen Univ Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP379

引用

页码：S324 / S325

页数：2

共 50 条

[31] EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
Perreault, Sebastien
Doz, Francois
Geoerger, Birgit
Italiano, Antoine
Lassen, Ulrik
Nilsson, Anna
Nysom, Karsten
Spano, Jean-Philippine
Norenberg, Ricarda
Bernard-Gauthier, Vadim
de la Cuesta, Esther
Drilon, Alexander
Laetsch, Theodore
van Tilburg, Cornelis
NEURO-ONCOLOGY, 2023, 25
[32] EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET
Perreault, Sebastien
Doz, Francois
Drilon, Alexander
Geoerger, Birgit
Boni, Valentina
Chisholm, Julia
Dubois, Steven G.
Grilley-Olson, Juneko E.
Hong, David S.
Italiano, Antoine
Kang, HyoungJin
Nysom, Karsten
Ora, Ingrid
Owens, Cormac
Schulte, Johannes H.
Tahara, Makoto
Ziegler, David
Ellezam, Benjamin
Reeves, John A.
Fellous, Marc
De La Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2020, 22 : 58 - 58
[33] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PAEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMOURS
Nysom, Karsten
Doz, Francois
Geoerger, Birgit
Ora, Ingrid
Perreault, Sebastien
Norenberg, Ricarda
Fellous, Marc
De La Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2022, 24 : 64 - 64
[34] Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers
Drilon, Alexander
Tan, Daniel S. W.
Lassen, Ulrik N.
Leyvraz, Serge
Liu, Yongmei
Patel, Jyoti D.
Rosen, Lee
Solomon, Benjamin
Norenberg, Ricarda
Dima, Laura
Brega, Nicoletta
Shen, Lin
Moreno, Victor
Kummar, Shivaani
Lin, Jessica J.
JCO PRECISION ONCOLOGY, 2022, 6
[35] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset
Boni, V.
Drilon, A.
Deeken, J.
Garralda, E.
Chung, H.
Kinoshita, I.
Oh, D.
Patel, J.
Xu, R.
Norenberg, R.
Brega, N.
Dima, L.
Hong, D.
Berlin, J.
ANNALS OF ONCOLOGY, 2021, 32 : S214 - S215
[36] ACTIVITY OF LAROTRECTINIB IN TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES
Patel, Jyoti D.
Farago, Anna F.
Hong, David S.
Lassen, Ulrik N.
Leyvraz, Serge
Park, Keunchil
Sohal, Davendra P. S.
Solomon, Benjamin
Reeves, John A.
Dima, Laura
Brega, Nicoletta
Drilon, Alexander
NEURO-ONCOLOGY, 2020, 22 : 41 - 42
[37] Larotrectinib efficacy and safety in adult TRK fusion cancer patients.
Hong, David S.
Kummar, Shivaani
Farago, Anna F.
Lassen, Ulrik Niels
Berlin, Jordan
Schilder, Russell J.
McDermott, Raymond S.
Patel, Jyoti D.
Dowlati, Afshin
Doebele, Robert Charles
Tan, Daniel Shao-Weng
Lee, James J.
Nanda, Shivani
Childs, Barrett H.
Ku, Nora
Drilon, Alexander E.
Hyman, David Michael
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[38] Larotrectinib efficacy and safety in pediatric TRK fusion cancer patients.
van Tilburg, Cornelis Martinus
DuBois, Steven G.
Albert, Catherine Michelle
Federman, Noah
Nagasubramanian, Ramamoorthy
Geoerger, Birgit
Orbach, Daniel
Bielack, Stefan S.
Shukla, Neerav Narendra
Turpin, Brian
Casanova, Michela
Spunt, Sheri L.
Qamoos, Hope
Nanda, Shivani
Childs, Barrett H.
Cox, Michael Craig
Pappo, Alberto S.
Laetsch, Theodore Willis
Mascarenhas, Leo
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[39] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Perreault, Sebastien
Drilon, Alexander
Lassen, Ulrik N.
Geoerger, Birgit
Nysom, Karsten
Ora, Ingrid
Gavrilovic, Igor T.
Norenberg, Ricarda
Bernard-Gauthier, Vadim
De la Cuesta, Esther
Laetsch, Theodore W.
Doz, Francois
Van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2022, 24 : 87 - 87
[40] EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Perreault, Sebastien
Doz, Francois
Geoerger, Birgit
Nysom, Karsten
Ora, Ingrid
Boni, Valentina
Chisholm, Julia
DuBois, Steven G.
Gerber, Nicolas U.
Goto, Hiroaki
Grilley-Olson, Juneko E.
Hansford, Jordan R.
Kang, Hyoung Jin
Capra, Michael
Schulte, Johannes H.
Stefanowicz, Joanna
Tahara, Makoto
Ziegler, David S.
Norenberg, Ricarda
Dima, Laura
De La Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2021, 23 : 42 - 42

← 1 2 3 4 5 →